Our Pricing

Best Weight Loss Injection Online UK: Expert Comparison Guide

Published on: June 03, 2026

Finding the best weight loss injection online UK requires understanding how each treatment works, their clinical evidence, and which suits your health profile. At Cured Pharmacy, our UK-registered clinical team offers transparent pricing on all licensed weight loss injections, with free online consultations completed in under three minutes and discreet delivery across the UK.

How GLP-1 Weight Loss Injections Work

GLP-1 receptor agonists are the most clinically effective weight loss injections available in the UK today. These medications mimic glucagon-like peptide-1, a natural hormone that regulates appetite, slows gastric emptying, and improves insulin sensitivity [1]. When administered weekly via subcutaneous injection, they significantly reduce hunger signals and help patients achieve sustained weight reduction.

Mounjaro (tirzepatide) represents the latest advancement in this class, functioning as a dual GIP/GLP-1 receptor agonist rather than targeting GLP-1 alone [2]. This dual mechanism produced average weight reductions of 22.5% over 72 weeks in the SURPASS-3 trial—substantially higher than single-pathway alternatives [2]. Wegovy (semaglutide) demonstrated average weight loss of 14.9% over 68 weeks in the STEP-1 trial, whilst Saxenda (liraglutide), administered daily, achieved 8% average reduction over 56 weeks [1][3].

All three medications require gradual dose escalation over several weeks to minimise gastrointestinal side effects. Your UK prescriber will determine your starting dose and titration schedule based on your medical history, current medications, and weight loss goals. These are prescription-only medicines in the UK and cannot be supplied without clinical assessment by a registered prescriber.

Mounjaro: The Most Effective Weight Loss Injection UK

Mounjaro received MHRA approval for chronic weight management in adults with a body mass index of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [2]. Common side effects include nausea, diarrhoea, and decreased appetite, typically most pronounced during dose escalation periods. These effects generally diminish as your body adjusts to the medication.

The injection technique is straightforward—administered subcutaneously in the abdomen, thigh, or upper arm using the pre-filled pen. Most patients find the once-weekly schedule more convenient than daily injections, improving long-term adherence. All Mounjaro supplied by Cured Pharmacy is UK-licensed, stored according to MHRA guidelines, and dispensed only after prescriber approval.

Clinical Evidence and Real-World Results

Tirzepatide's dual-action mechanism targets both GIP and GLP-1 receptors simultaneously, producing superior weight reduction compared to single-pathway treatments [2]. The SURMOUNT-1 trial enrolled 2,539 adults with obesity and demonstrated that 91% of participants on the highest maintenance dose achieved at least 5% weight loss, with 57% achieving 20% or greater reduction [4].

At Cured Pharmacy, Mounjaro is available from £135.00 for UK patients following online clinical assessment. The treatment comes in pre-filled KwikPen devices for once-weekly subcutaneous injection, with dose strengths ranging from 2.5mg starter doses up to 15mg maintenance doses. Your prescriber will determine the appropriate titration schedule based on your tolerance and response.

Wegovy vs Mounjaro: Comparing the Best Weight Loss Injection Online UK

Both medications require similar injection techniques and follow comparable dose escalation schedules. Wegovy starts at 0.25mg weekly, increasing gradually to a maintenance dose of 2.4mg, whilst Mounjaro begins at 2.5mg and may increase to 15mg depending on response and tolerance [2][3]. Your UK prescriber will recommend the most appropriate treatment based on your complete medical assessment.

Side effect profiles are broadly similar between the two medications, with gastrointestinal symptoms being most common. Approximately 44% of Wegovy users and 47% of Mounjaro users in clinical trials reported nausea during treatment, though most cases were mild to moderate and resolved without discontinuation [2][3]. Both treatments are contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Which Treatment Delivers Better Results?

Head-to-head comparisons show tirzepatide produces greater average weight reduction than semaglutide, though both represent significant advances over older treatments [2][4]. In clinical practice, the choice between Wegovy and Mounjaro often depends on individual tolerance, medical history, and prescriber assessment rather than efficacy alone.

Wegovy offers competitive pricing and robust clinical evidence from the STEP trial programme, making it an excellent option for many patients. The medication uses the same active ingredient as Ozempic (prescribed for type 2 diabetes) but at higher doses specifically licensed for weight management [3]. At Cured Pharmacy, Wegovy is available from £135.00, representing exceptional value compared to typical UK market rates.

Saxenda: Daily Weight Loss Injection Option

Saxenda (liraglutide) was the first GLP-1 receptor agonist licensed in the UK specifically for weight management, approved by the MHRA in 2015. Unlike weekly injections, Saxenda requires daily subcutaneous administration at the same time each day, starting at 0.6mg and increasing over five weeks to the maintenance dose of 3mg [1].

Clinical trials demonstrated that Saxenda produces average weight loss of 8% over 56 weeks when combined with reduced-calorie diet and increased physical activity [1]. Whilst this is lower than newer weekly alternatives, Saxenda remains an effective option for patients who prefer daily dosing or have medical considerations that make weekly injections unsuitable. At Cured Pharmacy, Saxenda is available from £135.00 following prescriber approval.

The daily injection schedule allows for more gradual dose adjustments and may suit patients concerned about side effects from higher weekly doses. However, adherence can be more challenging with daily administration compared to once-weekly options. Your UK prescriber will discuss whether Saxenda's dosing schedule aligns with your lifestyle and treatment preferences during your clinical assessment.

Wegovy Oral Tablets: Non-Injection Alternative

At Cured Pharmacy, Wegovy oral tablets are available from £135.00 for UK patients following online clinical assessment. The treatment begins at lower doses and gradually increases over several months to the target maintenance dose. Your prescriber will provide detailed instructions on proper administration technique to maximise absorption and efficacy.

Oral semaglutide offers genuine convenience for needle-averse patients whilst delivering the same active ingredient as Wegovy injections. However, the strict fasting requirements and timing restrictions mean some patients find weekly injections more practical for their daily routine. Your UK clinical team will help you weigh these considerations during your free consultation.

Semaglutide in Tablet Form

For patients who prefer to avoid injections entirely, Wegovy is now available in oral tablet form containing semaglutide. This represents a significant advancement, as GLP-1 medications are peptides that are normally broken down in the digestive system. The oral formulation uses absorption-enhancing technology to deliver therapeutic semaglutide levels without injection [5].

The tablets must be taken on an empty stomach with no more than 120ml of water, at least 30 minutes before any food, drink, or other medications. This strict administration requirement is essential for proper absorption. Clinical trials showed oral semaglutide produces comparable weight loss to the injectable form when taken correctly, though gastrointestinal side effects may be slightly more common [5].

Orlistat: Non-GLP-1 Weight Loss Treatment

The most common side effects relate to fat malabsorption—oily stools, increased bowel movements, and flatulence with discharge. These effects are directly related to dietary fat intake and can be minimised by following a lower-fat diet (less than 30% of calories from fat). Orlistat also reduces absorption of fat-soluble vitamins, so patients are advised to take a multivitamin supplement at bedtime.

Orlistat 120mg (prescription strength) is taken three times daily with meals containing fat, whilst Alli 60mg (over-the-counter strength) follows the same schedule at half the dose. Your UK prescriber will assess whether Orlistat suits your dietary patterns and weight loss goals. For patients seeking maximum efficacy, GLP-1 injections produce substantially greater weight reduction, but Orlistat remains a proven, affordable option for appropriate candidates.

How Orlistat Differs from Injectable Treatments

Orlistat works through an entirely different mechanism than GLP-1 injections—it blocks the absorption of approximately 30% of dietary fat consumed in meals by inhibiting pancreatic and gastric lipases [6]. The unabsorbed fat is then eliminated in stools, reducing overall calorie intake. This makes Orlistat particularly effective for patients whose diets contain moderate to higher fat content.

Clinical trials demonstrated average weight loss of 5-10% over one year when Orlistat is combined with a reduced-calorie diet [6]. Whilst this is lower than GLP-1 injections, Orlistat offers several advantages: it's taken orally as capsules, has been available in the UK for over two decades with extensive safety data, and costs significantly less than injectable alternatives. At Cured Pharmacy, generic Orlistat starts from £135.00, with branded Xenical from £135.00 and over-the-counter strength Alli from £135.00.

Scientific References

1. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11-22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2023). Two-year effects of tirzepatide on obesity and glycaemic control: the SURMOUNT-1 trial. Nature Medicine, 29(10), 2673-2681. https://doi.org/10.1038/s41591-023-02597-w [accessed 13 August 2026]
5. Knop, F. K., Aroda, V. R., do Vale, R. D., et al. (2023). Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402(10403), 705-719. https://doi.org/10.1016/S0140-6736(23)01185-6 [accessed 13 August 2026]
6. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to reduced-calorie diet and increased physical activity alongside medication. Clinical trial data represents average outcomes and does not guarantee individual results.